• Home
  • Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.

Author List
van 't Veer LJ, Yau C, Yu NY, Benz CC, Nordenskjöld B, Fornander T, Stål O, Esserman LJ, Lindström LS
Publication
Breast cancer research and treatment
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1214406
Publication Year
2017
PubMed ID
28776283
Publication Title
van 't Veer LJ, Yau C, Yu NY, Benz CC, Nordenskjöld B, Fornander T, Stål O, Esserman LJ, Lindström LS. Tamoxifen therapy benefit for patients with 70-gene signature high and low risk. Breast Cancer Res Treat. 2017 Nov; 166(2):593-601.